Updated CDC Zika laboratory testing guidance
Published Date:December 1, 2016
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations. ; American Society for Microbiology. ; Association of Public Health Laboratories (U.S.)
Series:COCA Conference Call
Description:Guidance for US Laboratories Testing for Zika Virus Infection / Christy Ottendorfer -- ￼Diagnostic Testing for Zika Virus in Clinical Laboratories / Matthew J. Binnicker -- All Hands Response for Zika Testing / Grace Kubin.
Clinician Outreach and Communication Activity (COCA) conference call Thursday, December 1, 2016.
CDC and several state and local health departments are testing for Zika virus. Every day, CDC learns more about Zika. CDC has recently released revised Zika virus laboratory testing guidance. During this COCA Call, clinicians will learn about the updated recommendations in CDC’s Guidance for U.S. Laboratories Testing for Zika Virus Infection and understand their role in testing specimens collected from patients. In addition, subject matter experts from CDC, the American Society for Microbiology, and the Association of Public Health Laboratories will discuss changes to the CDC Trioplex Real-time RT-PCR (rRT-PCR) Assay Emergency Use Authorization, examine the use of non-CDC developed assays, and review recommendations for plaque reduction neutralization testing in Puerto Rico.
• Describe all available Food and Drug Administration Emergency Use Authorizations for Zika virus assays.
• Discuss Zika virus testing methods, including molecular and antibody detection.
• Explain the role of public health laboratories, clinicians, and health departments in Zika testing and diagnosis.
You May Also Like: